How does epigenetic mechanism impact Type 2 diabetes?
September 20, 2024 @ 13:00 – 14:00 CEST
Speaker: Dr. Charlotte Ling is a Professor at Lund University
Dr. Charlotte Ling is a Professor at Lund University and a principal investigator of the Epigenetics and Diabetes Unit at Lund University Diabetes Centre (LUDC). She obtained her PhD in Endocrinology at University of Gothenburg, Sweden in 2002. After a postdoc at Lund University, where she studied genetics of type 2 diabetes, she dedicated her research to the study of epigenetic mechanisms causing type 2 diabetes and metabolic disease. Her research group has over the last two decades pioneered the field of epigenetics in type 2 diabetes. They have made several groundbreaking discoveries such as genome-wide epigenetic modifications in pancreatic islets, skeletal muscle, adipose tissue and the liver from patients with type 2 diabetes compared with non-diabetic control subjects. Dr. Ling’s research group has also shown that genetic and non-genetic factors such as SNPs, exercise, diet, obesity and age alter the genome-wide epigenetic pattern in human primary tissues for type 2 diabetes. More recently, her group is trying to translate their epigenetic findings to biomarkers and novel therapies for precision medicine to improve prediction, prevention and treatments of type 2 diabetes.
Host: Louella Vasquez, NBIS (louella.vasquez@scilifelab.se)
Broadcast link (live event): https://lu-se.zoom.us/j/67681656100
The talk will also be available afterwards on the NBIS YouTube channel.
info@nbis.se
Google Calendar 
